In addition, the conjugation of PDGFB cycle peptides makes the nanoswitch recognize the tumor site specifically [26–32], allowing the nanoswitch to be effectively internalized by tumor cells and accumulate preferentially at tumor sites. This evidence concerns the gene PDGFB and neoplasm.